Apotex gets FDA ultimatum; Teva recalls propofol
> Apotex got an ultimatum from the FDA: Fix your manufacturing problems, or forget introducing new meds in the U.S. Report
> Teva, maker of the anesthetic propofol, has a massive recall underway following dozens of patients getting sick from two batches. Bacterial contamination is the chief suspect. Article
> EMCOR will provide facilities and energy management services for Patheon at the contract manufacturer's three U.S. plants in Manati and Caguas, Puerto Rico, and Cincinnati. Release
> A groundbreaking ceremony took place recently for a planned 200,000-square-foot, $30-million Viva Biopharm manufacturing plant in Blaine, WA. Article
> The Pharmaceutical Council of Nigeria cites an increasing rate of fake pharmaceutical products in circulation, and attributed the trend to the failure of manufacturers to conform to standards. Article
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: